HLA DR15 (DR2) Immunosuppressive Response Association in Myelodysplastic Syndrome (MDS)
Also known as: DR15, Immunosuppressive Response, MDS, Myelodysplastic Syndrome
Use
Determine the presence of DR15 antigen.
Special Instructions
When submitting buccal swabs, it is essential to use a buccal swab kit provided by LabCorp. For obtaining the buccal swab kit or additional assistance in selecting the appropriate HLA test, please contact LabCorp's HLA customer service at the specified number. This ensures proper specimen collection and handling, which is crucial for accurate test results.
Limitations
Despite all the necessary precautions, there may be instances where the specimen is not suitable for testing, necessitating a recollection. The test has been developed and characterized by LabCorp, with performance metrics available, though it has not received FDA clearance or approval for diagnostic use. Variations in specimen collection and handling can significantly impact test accuracy and reliability.
Methodology
NGS (Targeted)
Biomarkers
LOINC Codes
- 6803-1
- 49549-9
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL
Minimum Volume
3 mL
Container
Lavender-top (EDTA) tube
Storage Instructions
Maintain blood specimen at room temperature.
Causes for Rejection
Hemolysis; clotted specimen; yellow-top (ACD) tube
Other tests from different labs that may be relevant